<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>PubTator</source><date>2020-12-04</date><key>BioC.key</key>
<document><id>28481877</id><passage><infon key="type">title</infon><offset>0</offset><text>CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis.</text><annotation id="0"><infon key="NCBI Gene identifier">1579</infon><infon key="type">GENERIF</infon><location offset="0" length="5"/><text>CYP4A</text></annotation></passage><passage><infon key="type">abstract</infon><offset>94</offset><text>Tumor-associated macrophages (TAMs) play an essential role in metastasis. However, what enables TAMs to have a superior capacity to establish pre-metastatic microenvironment in distant organs is unclear. Here we have begun to uncover the effects of cytochrome P450 (CYP) 4A in TAMs on lung pre-metastatic niche formation and metastasis. CYP4A(+) TAM infiltration was positively associated with metastasis, pre-metastatic niche formation and poor prognosis in breast cancer patients. The pharmacological inhibition of CYP4A reduced lung pre-metastatic niche formation (evidenced by a decrease in vascular endothelial growth factor receptor 1 positive (VEGFR1(+)) myeloid cell recruitment and pro-metastatic protein expression) and metastatic burden, accompanied with TAM polarization away from the M2 phenotype in spontaneous metastasis models of 4T1 breast cancer and B16F10 melanoma. Co-implantation of 4T1 cells with CYP4A10(high) macrophages promoted lung pre-metastatic niche formation and metastasis. Depletion of TAMs disrupted lung pre-metastatic niches and thereby prevented metastasis. Treatment with the CM from CYP4A10(high) M2 macrophages (M2) increased pre-metastatic niche formation and metastatic burden in the lungs, whereas CYP4A inhibition attenuated these effects. In vitro TAM polarization away from the M2 phenotype induced by CYP4A inhibition decreased VEGFR1(+) myeloid cell migration and fibronectin expression, accompanied with downregulation of STAT3 signaling. Conversely, overexpression of CYP4A or exogenous addition of 20-hydroxyeicosatetraenoic acid promoted M2 polarization and cytokine production of macrophages and thereby enhanced migration of VEGFR1(+) myeloid cells, which were reversed by siRNA or pharmacological inhibition of STAT3. Importantly, a combined blocking M2 macrophage-derived factors TGF-β, VEGF and SDF-1 abolished VEGFR1(+) myeloid cell migration and fibroblast activation induced by CYP4A. In summary, CYP4A in TAMs is crucial for lung pre-metastatic niche formation and metastasis, and may serve as a potential therapeutic target in human cancer.</text><annotation id="1"><infon key="code">333</infon><infon key="NCBI Gene identifier">1579</infon><infon key="type">STARGENE</infon><location offset="343" length="15"/><text>cytochrome P450</text></annotation><annotation id="2"><infon key="NCBI Gene identifier">13117</infon><infon key="type">GENERIF</infon><location offset="343" length="24"/><text>cytochrome P450 (CYP) 4A</text></annotation><annotation id="3"><infon key="code">333</infon><infon key="NCBI Gene identifier">1579</infon><infon key="type">STARGENE</infon><location offset="359" length="8"/><text>(CYP) 4A</text></annotation><annotation id="4"><infon key="code">333</infon><infon key="NCBI Gene identifier">1579</infon><infon key="type">STARGENE</infon><location offset="431" length="5"/><text>CYP4A</text></annotation><annotation id="5"><infon key="NCBI Gene identifier">13117</infon><infon key="type">GENERIF</infon><location offset="611" length="5"/><text>CYP4A</text></annotation><annotation id="6"><infon key="NCBI Gene identifier">14254</infon><infon key="type">Gene</infon><location offset="689" length="45"/><text>vascular endothelial growth factor receptor 1</text></annotation><annotation id="7"><infon key="NCBI Gene identifier">14254</infon><infon key="type">Gene</infon><location offset="745" length="6"/><text>VEGFR1</text></annotation><annotation id="8"><infon key="NCBI Gene identifier">13117</infon><infon key="type">GENERIF</infon><location offset="1013" length="7"/><text>CYP4A10</text></annotation><annotation id="9"><infon key="NCBI Gene identifier">13117</infon><infon key="type">GENERIF</infon><location offset="1216" length="7"/><text>CYP4A10</text></annotation><annotation id="10"><infon key="code">333</infon><infon key="NCBI Gene identifier">13117</infon><infon key="type">STARGENE</infon><location offset="1335" length="5"/><text>CYP4A</text></annotation><annotation id="11"><infon key="code">333</infon><infon key="NCBI Gene identifier">13117,1579</infon><infon key="type">STARGENE</infon><location offset="1442" length="5"/><text>CYP4A</text></annotation><annotation id="12"><infon key="NCBI Gene identifier">14254</infon><infon key="type">Gene</infon><location offset="1469" length="6"/><text>VEGFR1</text></annotation><annotation id="13"><infon key="NCBI Gene identifier">2335</infon><infon key="type">Gene</infon><location offset="1506" length="11"/><text>fibronectin</text></annotation><annotation id="14"><infon key="NCBI Gene identifier">20848</infon><infon key="type">Gene</infon><location offset="1565" length="5"/><text>STAT3</text></annotation><annotation id="15"><infon key="code">333</infon><infon key="NCBI Gene identifier">13117,1579</infon><infon key="type">STARGENE</infon><location offset="1612" length="5"/><text>CYP4A</text></annotation><annotation id="16"><infon key="NCBI Gene identifier">2321</infon><infon key="type">Gene</infon><location offset="1773" length="6"/><text>VEGFR1</text></annotation><annotation id="17"><infon key="NCBI Gene identifier">6774</infon><infon key="type">Gene</infon><location offset="1860" length="5"/><text>STAT3</text></annotation><annotation id="18"><infon key="NCBI Gene identifier">21803</infon><infon key="type">Gene</infon><location offset="1930" length="5"/><text>TGF-β</text></annotation><annotation id="19"><infon key="NCBI Gene identifier">22339</infon><infon key="type">Gene</infon><location offset="1937" length="4"/><text>VEGF</text></annotation><annotation id="20"><infon key="NCBI Gene identifier">20315</infon><infon key="type">Gene</infon><location offset="1946" length="5"/><text>SDF-1</text></annotation><annotation id="21"><infon key="NCBI Gene identifier">2321</infon><infon key="type">Gene</infon><location offset="1962" length="6"/><text>VEGFR1</text></annotation><annotation id="22"><infon key="code">333</infon><infon key="NCBI Gene identifier">13117</infon><infon key="type">STARGENE</infon><location offset="2032" length="5"/><text>CYP4A</text></annotation><annotation id="23"><infon key="code">333</infon><infon key="NCBI Gene identifier">1579</infon><infon key="type">STARGENE</infon><location offset="2051" length="5"/><text>CYP4A</text></annotation></passage></document>
</collection>
